2. Inflammation/Immunology

Inflammation/Immunology

Inflammation/Immunology

Related Products

PDF 93.1 MB

The diseases caused by disorders of the immune system fall into two broad categories: immunodeficiency and autoimmunity. Immunotherapy is also often used in the immunosuppressed (such as HIV patients) and people suffering from other immune deficiencies or autoimmune diseases. This includes regulating factors such as IL-2, IL-10, IFN-α. Infection with HIV is characterized not only by development of profound immunodeficiency but also by sustained inflammation and immune activation. Chronic inflammation as a critical driver of immune dysfunction, premature appearance of aging-related diseases, and immune deficiency.

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-P990473
    Anti-MUSK Antibody 98%
    Anti-MUSK Antibody
  • HY-P990474
    Anti-NGF/bNGF Antibody 98%
    Anti-NGF/bNGF Antibody is a CHO-expressed humanized antibody that targets NGF/bNGF. Anti-NGF/bNGF Antibody has a huIgG2a heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 144.14 kDa. The isotype control for Anti-NGF/bNGF Antibody can be referenced as Human IgG2 kappa, Isotype Control (HY-P99002).
    Anti-NGF/bNGF Antibody
  • HY-P990475
    Anti-Nogo Receptor/NgR Antibody 98%
    Anti-Nogo Receptor/NgR Antibody
  • HY-P990476
    Anti-NOTCH1 Antibody 98%
    The Anti-NOTCH1 Antibody is a CHO-expressed human antibody targeting NOTCH1. The Anti-NOTCH1 Antibody has a huIgG2 heavy chain and a huλ light chain, with a predicted molecular weight (MW) of 150 kDa. The isotype control for the Anti-NOTCH1 Antibody can refer to Human IgG2 kappa, Isotype Control (HY-P99002).
    Anti-NOTCH1 Antibody
  • HY-P990477
    Anti-NOTCH3 Antibody 98%
    Anti-NOTCH3 Antibody
  • HY-P990478
    Anti-Orai1 Antibody 98%
    Anti-Orai1 Antibody is a humanized antibody expressed in CHO cells that targets Orai1. The Anti-Orai1 Antibody has a huIgG2 heavy chain and a huλ light chain, with an predicted molecular weight (MW) of 150 kDa. The isotype control for Anti-Orai1 Antibody can refer to Human IgG2 kappa, Isotype Control (HY-P99002).
    Anti-Orai1 Antibody
  • HY-P990479
    Anti-OX2R/CD200R1 Antibody 98%
    Anti-OX2R/CD200R1 Antibody is a CHO-expressed human antibody that targets OX2R/CD200R1. The predicted molecular weight (MW) of Anti-OX2R/CD200R1 Antibody is 146.58 kDa. The isotype control for Anti-OX2R/CD200R1 Antibody can refer to Human IgG4 kappa, Isotype Control (HY-P99003).
    Anti-OX2R/CD200R1 Antibody
  • HY-P990480
    Anti-oxLDL Antibody 98%
    The Anti-oxLDL Antibody is a humanized antibody expressed in CHO cells that targets oxLDL. The Anti-oxLDL Antibody has a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 150 kDa. The isotype control for the Anti-oxLDL Antibody can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).
    Anti-oxLDL Antibody
  • HY-P990481
    Anti-PACAP38 Antibody 98%
    Anti-PACAP38 Antibody is a human antibody expressed in CHO cells, targeting PACAP38. The Anti-PACAP38 Antibody has a huIgG4SP type heavy chain and a huκ type light chain, with a predicted molecular weight (MW) of 150 kDa. The isotype control for Anti-PACAP38 Antibody can refer to Human IgG4 kappa, Isotype Control (HY-P99003).
    Anti-PACAP38 Antibody
  • HY-P990482
    Anti-PAR2 Antibody 98%
    Anti-PAR2 Antibody
  • HY-P990483
    Anti-PAR2 Antibody (PAR650097) 98%
    Anti-PAR2 Antibody (PAR650097)
  • HY-P990484
    Anti-PCLA Antibody 98%
    Anti-PCLA Antibody
  • HY-P990485
    Anti-PCSK9 Antibody 98.39%
    Anti-PCSK9 Antibody is a human antibody expressed in CHO, targeting PCSK9. Anti-PCSK9 Antibody contains a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 145 kDa. The isotype control for Anti-PCSK9 Antibody can refer to Human IgG1 kappa, Isotype Control (HY-P99001).
    Anti-PCSK9 Antibody
  • HY-P990486
    Anti-PDCD1/PD-1/CD279 Antibody 98%
    Anti-PDCD1/PD-1/CD279 Antibody is a CHO-expressed humanized antibody that targets PDCD1/PD-1/CD279. Anti-PDCD1/PD-1/CD279 Antibody has a huIgG4SP type heavy chain and a huκ type light chain, with a predicted molecular weight (MW) of 150 kDa. The isotype control for Anti-PDCD1/PD-1/CD279 Antibody can refer to Human IgG4 kappa, Isotype Control (HY-P99003).
    Anti-PDCD1/PD-1/CD279 Antibody
  • HY-P990487
    Anti-PDGFB Antibody (MOR-8457) 99.29%
    Anti-PDGFB Antibody (MOR-8457)
  • HY-P990488
    Anti-PDGFC/VEGFE Antibody 98%
    Anti-PDGFC/VEGFE Antibody
  • HY-P99048A
    Sintilimab (Anti-PD-1) 98%
    Sintilimab (Anti-PD-1) (IBI308 (Anti-PD-1)) is a safe and effectivel humanized IgG4 monoclonal antibody that binds to PD-1 with a KD value of 74 pM. Sintilimab (Anti-PD-1) blocks the interaction of PD-1 with its ligands (PD-L1 and PL-L2), consequently helping to restore the endogenous antitumour T-cell response. Sintilimab (Anti-PD-1) combined with prebiotics inhibits tumor volume and regulates immune cell subpopulation balance in lung adenocarcinoma mice. Sintilimab (Anti-PD-1) can be used for the research of classical Hodgkin's lymphoma, non-small cell lung cancer and oesophageal cancer.
    Sintilimab (Anti-PD-1)
  • HY-P990490
    Anti-PGLYRP1/PGRP-S Antibody 98%
    Anti-PGLYRP1/PGRP-S Antibody
  • HY-P990491
    Anti-PLA2G1B Antibody 98%
    Anti-PLA2G1B Antibody
  • HY-P990492
    Anti-PMEL Antibody 98%
    Anti-PMEL Antibody
Cat. No. Product Name / Synonyms Application Reactivity